Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “vaccine”

821 pharma patents match "vaccine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 821
Index total 30,257
Page 4 / 35

Quick answer

This filtered view shows 821 pharmaceutical patents matching "vaccine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

821 results for “vaccine” · 30,257 patents in full index Clear search

  1. CA 3260357

    RÉGIME DE PRIMO-IMMUNISATION DE VIRUS DE LA VACCINE ANKARA (MVA) ET DE PETIT ARN ACTIVATEUR (VRP) MODIFIÉS RECOMBINANTS

    BAVARIAN NORDIC AS [DK] · Granted Jan 4, 2024 · Expires Dec 30, 2043

    granted

  2. US 11857613

    Vaccine for prevention of necrotic enteritis in poultry

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted

  3. US 11859000

    Anti-CCR8 antibodies and uses thereof

    VACCINEX, INC. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted

  4. US 11844830

    Vaccines for human papilloma virus and methods for using the same

    Inovio Pharmaceuticals, Inc. · Granted Dec 19, 2023 · Expires Dec 14, 2043

    granted

  5. US 11839650

    Universal influenza vaccine targeting virus/host recognition

    The Board of Regents of the University of Texas System · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted

  6. US 11826415

    Method of conferring a protective immune response to Norovirus

    Takeda Vaccines, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  7. US 11813319

    Development of a novel live attenuated African Swine Fever vaccine based in the deletion of gene I177L

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 14, 2023 · Expires Nov 9, 2043

    granted

  8. US 11801296

    Development of a novel live attenuated African swine fever vaccine based in the deletion of gene A137R

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted

  9. US 11801218

    Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine

    The Board of Regents of the University of Texas System · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted

  10. US 11801288

    Cancer vaccines and methods of treatment using the same

    Inovio Pharmaceuticals, Inc. · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted

  11. US 11801298

    MERS-CoV vaccine

    Inovio Pharmaceuticals, Inc. · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted

  12. US 11786589

    Human rotavirus strains and vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  13. US 11771751

    Streptococcal GlcNAc-lacking glycopolypeptides, cell wall carbohydrates, streptococcus vaccines, and methods for making and using them

    The Regents of the University of California · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  14. US 11771752

    Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins

    Prime Bio, Inc. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  15. US 11766476

    Genomic deletion in African swine fever vaccine allowing efficient growth in stable cell lines

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 26, 2023 · Expires Sep 21, 2043

    granted

  16. US 11759513

    Human rotavirus G9P[6] strain and use as a vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted

  17. US 11753627

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted

  18. US 11744887

    Coronavirus vaccine compositions and methods

    ARCTURUS THERAPEUTICS, INC. · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted

  19. US 11744885

    Vaccines for recurrent respiratory papillomatosis and methods of using the same

    Inovio Pharmaceuticals, Inc. · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted

  20. US 11746335

    Development of dengue virus vaccine components

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted

  21. US 11730802

    Zika vaccines and immunogenic compositions, and methods of using the same

    Takeda Vaccines, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  22. US 11730799

    Cancer vaccines and methods of producing and using same

    THE UNITED STATES GOVERNMENT DEPARTMENT OF VETERANS AFFAIRS · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  23. US 11730801

    Live attenuated Zika virus with 3'UTR deletion, vaccine containing and use thereof

    The Board of Regents of the University of Texas System · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  24. US 11701421

    Compositions and methods for stabilizing flaviviruses with improved formulations

    Takeda Vaccines, Inc. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.